These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3388295)

  • 21. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
    Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
    Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies.
    Castaman G; Bona ED; Schiavotto C; Trentin L; D'Emilio A; Rodeghiero F
    Haematologica; 1997; 82(5):584-7. PubMed ID: 9407726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
    Kätzel R; Dietzel H; Selle B; Taube C
    Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gray-platelet syndrome associated with Marfan disease in a Mexican family].
    Martínez-Murillo C; Payns Borrego E; Arzate Hernández G; Soriano Rosas J; Ambriz Fernández R; Marín Palomares T; Quintana González S
    Sangre (Barc); 1994 Aug; 39(4):287-91. PubMed ID: 7985059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.
    Mörsdorf S; Köhler M; Leipnitz G; Wenzel E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times.
    Marti GE; Rick ME; Sidbury J; Gralnick HR
    Blood; 1986 Jul; 68(1):180-4. PubMed ID: 3087438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
    Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [May-Hegglin anomaly: further studies on thrombocyte dysfunction].
    Mayer K; Schildknecht O; von Felten A
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1134-40. PubMed ID: 9312836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery.
    Kentro TB; Lottenberg R; Kitchens CS
    Am J Hematol; 1987 Feb; 24(2):215-9. PubMed ID: 3101493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of patients with bleeding disorder to DDAVP administration.
    Chuansumrit A; Hathirat P; Pintadit P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():174-9. PubMed ID: 7886567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmopressin (dDAVP): a powerful general hemostatic agent?
    Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.